Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis

G C Gilmore1, P J Whitehouse

  • 1Department of Psychology, Case Western Reserve University, Cleveland, Ohio, USA.

Optometry and Vision Science : Official Publication of the American Academy of Optometry
|February 1, 1995
PubMed
Summary

Alzheimer's disease (AD) patients show a significant decline in spatial contrast sensitivity, particularly for flickering visual stimuli, over one year. This visual change may indicate accelerated cell loss in the magnocellular pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical issues in dementia.

Dialogues in clinical neuroscience·2011
Same author

When are nonwords easy to see?

Memory & cognition·2011
Same author

The role of nutrients in the prevention and treatment of Alzheimer's disease: methodology for a systematic review.

European journal of neurology·2009
Same author

Speaking of research advance directives: planning for future research participation.

Neurology·2006
Same author

Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease.

The Journal of neuropsychiatry and clinical neurosciences·2004
Same author

Donepezil.

Drugs of today (Barcelona, Spain : 1998)·2004

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Gerontology

Background:

  • Spatial contrast sensitivity is crucial for visual perception and can be affected by aging and neurodegenerative diseases.
  • Alzheimer's disease (AD) is associated with visual processing deficits, but the specific mechanisms are not fully understood.
  • The magnocellular (M) visual pathway is implicated in processing motion and low-contrast stimuli, and its dysfunction has been reported in AD.

Purpose of the Study:

  • To evaluate changes in spatial contrast sensitivity over a 1-year period in normal elderly adults and individuals with probable Alzheimer's disease (AD).
  • To investigate potential differences in visual processing decline between aging and AD progression.
  • To explore the relationship between spatial contrast sensitivity deficits and the integrity of the magnocellular visual pathway in AD.

Related Experiment Videos

Main Methods:

  • Longitudinal study design with three assessment sessions over 1 year.
  • Measurement of spatial contrast sensitivity using static and flickering (7.5 Hz) stimuli in normal elderly controls and probable AD patients.
  • Analysis of sensitivity changes in relation to spatial frequency and temporal modulation.

Main Results:

  • Both normal elderly adults and AD patients exhibited a decline in contrast sensitivity for static, high spatial frequencies over 1 year.
  • A significant decline in sensitivity to flickered stimuli was observed specifically in AD patients, unlike normal elderly adults who maintained stable sensitivity.
  • AD patients showed a pronounced decrease in sensitivity for low contrast, high temporal frequency stimuli.

Conclusions:

  • The significant decline in sensitivity to flickered stimuli in AD patients suggests a specific vulnerability of the magnocellular (M) visual pathway.
  • Spatial contrast sensitivity changes in AD may reflect a more rapid loss of M-channel cells at retinal and cortical levels.
  • These findings highlight the potential of spatial contrast sensitivity testing as a biomarker for AD progression and M-channel dysfunction.